Treatment with thapsigargin, an endoplasmic reticulum (ERS) inducer (Figure 3), led to a marked decrease in Thr-32 phosphorylation of Foxo3a and an elevated nuclear-to-cytoplasmic Foxo3a ratio in neuroblastoma cells (Zhu et al., 2004). Here, FOXO3 is linked to neuroblastoma.